GLG News Analyses of the following article:

European medical advisory committee does not recommend approval of Avastin for deadly form of brain cancer

view article

Published at: www.pipelinereview.com

Donald Fleming, Director of the Cancer Care Center

Donald FlemingDirector of the Cancer Care Center DAVIS HEALTH SYSTEM, INC. What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Roche's Avastin declined by European "bean counters" for brain tumor

November 23, 2009

Avastin utilized successfully in US for primary brain tumors, including the very aggressive GBMHealth care, including cancer, will be all about rationingRoche and other pharma companys better get ready for a rough future

Subscribe to Updates

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines

Work for one of the world's leading organizations? Get started now.

Get Intelligently Connected
with the world's leading experts

GLG's 850+ Clients Include:

More than 70% of the world's leading
mutual funds
15 of the leading 20
global banks
9 of the leading 10
global private equity firms
5 of the leading 10
AmLaw firms
Fortune 500® Companies
in nearly every industry sector, including pharmaceuticals, insurance, chemicals, energy and computer software